New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 11, 2009
08:14 EDTAMLN
theflyonthewall.com: Amylin Pharma December volatility at 67, April at 77
Amylin Pharma closed at $12.37. Amylin markets a diabetes drug called Byetta. Amylin December option implied volatility is at 67, January is at 65, April is at 77; verses its 26-week average of 69, according to Track Data, suggesting larger spring price movement. :theflyonthewall.com



News For AMLN From The Last 14 Days
Check below for free stories on AMLN the last two weeks.
There are 25 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 13, 2012
08:05 EDTAMLN
theflyonthewall.com: Amylin, Alkermes announce BYDUREON once-weekly available in U.S. pharmacies

Subscribe for More Information
:theflyonthewall.com

February 9, 2012
16:27 EDTAMLN
theflyonthewall.com: Leerink's biotech and pharmaceuticals analysts hold a conference call
Biotech Analysts Schimmer and Liang, along with Pharmaceuticals Analyst Fernandez, review the reimbursement process for drugs in France on an Analyst/Industry conference call. Relevant covered companies ACOR, AMGN, AMLN, AUXL, BIIB, BMY, GILD, HGSI, ITMN, JNJ, NVS, PFE and VRTX may be included on the Analyst/Industry conference call to be held on February 10 at 11 am. :theflyonthewall.com

February 7, 2012
09:57 EDTAMLN
theflyonthewall.com: Gappers report: Bullish gaps

Subscribe for More Information
:theflyonthewall.com
09:24 EDTAMLN
theflyonthewall.com: Pre-market top 5 gainers
The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. CSTR 18%, AMLN 4.8%, PRGO 4.2%, HGSI 2.3%, DNDN 1%. :theflyonthewall.com
07:58 EDTAMLN
theflyonthewall.com: Amylin price target raised to $19 from $17 at RW Baird
Baird raised its price target on Amylin following Q4 results. The firm cited the potential for a successful US partnership transaction and the launch of Bydureon on February 17. Shares are Outperform rated. :theflyonthewall.com
07:46 EDTAMLN
theflyonthewall.com: Amylin target raised to $26 from $17 at BMO Capital

Subscribe for More Information
:theflyonthewall.com
07:04 EDTAMLN
theflyonthewall.com: Amylin price target raised to $30 from $25 at Jefferies

Subscribe for More Information
:theflyonthewall.com
07:02 EDTAMLN
theflyonthewall.com: Amylin sees 2012 non-GAAP operating loss $20M-$40M
The company sees 2012 GAAP operating expense of $600M-$625M. Guidance was issued on Amylin's earnings conference call last night. :theflyonthewall.com

February 6, 2012
16:48 EDTAMLN
theflyonthewall.com: Amylin reports Q4 non-GAAP net income 9c vs. consensus (8c)

Subscribe for More Information
:theflyonthewall.com
16:45 EDTAMLN
theflyonthewall.com: Amylin reports Q4 Byetta revenue $132.6M

Subscribe for More Information
:theflyonthewall.com
16:44 EDTAMLN
theflyonthewall.com: Amylin reports Q4 net product sales $160.9M

Subscribe for More Information
:theflyonthewall.com
16:44 EDTAMLN
theflyonthewall.com: Amylin reports Q4 EPS ($3.15) vs. consensus (8c)
Reports Q4 revenue $164.94M vs. consensus $163.64M :theflyonthewall.com
09:01 EDTAMLN
theflyonthewall.com: Amylin breaks lower in pre-market trading, support is at $16.29, then $15.55
:theflyonthewall.com
08:14 EDTAMLN
theflyonthewall.com: Amylin price target lowered to $7.50 from $10 at Imperial Capital

Subscribe for More Information
:theflyonthewall.com

January 31, 2012
11:21 EDTAMLN
theflyonthewall.com: Piper Jaffray's biotech and specialty pharma analysts hold a conference call

Subscribe for More Information
:theflyonthewall.com

January 30, 2012
12:14 EDTAMLN
theflyonthewall.com: On The Fly: Mid-Day Wrap

Subscribe for More Information
:theflyonthewall.com
12:00 EDTAMLN
theflyonthewall.com: Amylin rises 19%

Subscribe for More Information
:theflyonthewall.com
10:02 EDTAMLN
theflyonthewall.com: Gappers report

Subscribe for More Information
:theflyonthewall.com
09:19 EDTAMLN
theflyonthewall.com: Pre-market top 5 gainers

Subscribe for More Information
:theflyonthewall.com
09:06 EDTAMLN
theflyonthewall.com: Amylin downgraded to Neutral from Buy at Summer Street
Summer Street downgraded Amylin following approval of Bydureon. :theflyonthewall.com
09:00 EDTAMLN
theflyonthewall.com: Amylin rises 15.6%
Amylin is up 15.6%, or $1.89, to $14.03 :theflyonthewall.com
08:14 EDTAMLN
theflyonthewall.com: Amylin rises on Bydureon approval, resistance is at $14.60, a pivot high

Subscribe for More Information
:theflyonthewall.com
08:07 EDTAMLN
theflyonthewall.com: Alkermes approval opens growth drivers, says Cowen

Subscribe for More Information
:theflyonthewall.com
07:59 EDTAMLN
theflyonthewall.com: Amylin could be acquired for $33 per share, says Piper Jaffray

Subscribe for More Information
:theflyonthewall.com
07:57 EDTAMLN
theflyonthewall.com: Amylin price target raised to $17 from $15 at RW Baird

Subscribe for More Information
:theflyonthewall.com